SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001140361-22-032898
Filing Date
2022-09-09
Accepted
2022-09-09 16:13:50
Documents
16
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A brhc10041761_10qa.htm   iXBRL 10-Q/A 44944
2 EXHIBIT 31.1 brhc10041761_ex31-1.htm EX-31.1 11291
3 EXHIBIT 31.2 brhc10041761_ex31-2.htm EX-31.2 11980
4 EXHIBIT 31.3 brhc10041761_ex31-3.htm EX-31.3 6348
5 EXHIBIT 31.4 brhc10041761_ex31-4.htm EX-31.4 6997
  Complete submission text file 0001140361-22-032898.txt   251495

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA kron-20220331.xsd EX-101.SCH 3868
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE kron-20220331_lab.xml EX-101.LAB 24117
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kron-20220331_pre.xml EX-101.PRE 17102
10 EXTRACTED XBRL INSTANCE DOCUMENT brhc10041761_10qa_htm.xml XML 5692
Mailing Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402
Business Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402 212-871-7920
Kronos Bio, Inc. (Filer) CIK: 0001741830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-39592 | Film No.: 221236338
SIC: 2834 Pharmaceutical Preparations